Use este identificador para citar ou linkar para este item: http://repositorio.bc.ufg.br/handle/ri/17530
Registro completo de metadados
Campo DCValorIdioma
dc.creatorFreitas, Luiz Guilherme Azevedo de-
dc.creatorPaiva, Roberta Albuquerque de Azevedo-
dc.creatorCallou, Thais Maria Pinheiro-
dc.creatorAraújo, Danielle de Albuquerque Carrera-
dc.creatorFreitas Neto, Clovis Arcoverde de-
dc.creatorCouceiro, Tania Cursino de Menezes-
dc.creatorFreitas Neto, Theophilo José de-
dc.creatorÁvila, Marcos Pereira de-
dc.date.accessioned2019-05-13T15:53:58Z-
dc.date.available2019-05-13T15:53:58Z-
dc.date.issued2014-
dc.identifier.citationFREITAS, Luiz Guilherme Azevedo de et al. Efficacy of sublingual use of ketorolac tromethamine in reducing pain during treatment with laser photocoagulation in patients with diabetic retinopathy double blind, randomized, sham-controlled study. Journal of Clinical & Experimental Ophthalmology, Hyderabad, v. 5, n. 5, p. 1-3, 2014.pt_BR
dc.identifier.issne- 2155-9570-
dc.identifier.urihttp://repositorio.bc.ufg.br/handle/ri/17530-
dc.description.abstractObjective: To evaluate the analgesic effect of sublingual ketorolac tromethamine during argon laser photocoagulation in patients with diabetic retinopathy. Methods: A double blind, randomized, sham - controlled study, was conducted in 60 patients with diabetic retinopathy, referred for argon laser panretinal photocoagulation (PRP). For the evaluation of pain intensity, a numerical scale from zero to ten was used. The trial sample was divided into two groups. Group 1 consisted of 27 patients who used one 10 mg tablet of ketorolac tromethamine and group 2 comprised of 33 patients who used a sham, both with the same method of administration, 30 minutes before application of the laser. Results: Of the 27 patients in Group 1, 20 (74%) felt pain in the first stage, 5 (19%) experienced pain in the second stage and 2 (7%) felt no pain at any time. Of the 33 patients in Group 2, 27 (82%) felt pain in the first stage, 3 (9%) experienced pain in the second stage and 3 (9%) felt no pain at any time. There was no statistically significant difference between the groups (p=0.65 and 0.33). Conclusion: Ketorolac tromethamine was not able to reduce pain during panretinal photocoagulation in patients with proliferative diabetic retinopathy.pt_BR
dc.language.isoengpt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectLaser photocoagulationpt_BR
dc.subjectDiabetic retinopathypt_BR
dc.subjectPain managementpt_BR
dc.subjectKetorolac tromethaminept_BR
dc.titleEfficacy of sublingual use of ketorolac tromethamine in reducing pain during treatment with laser photocoagulation in patients with diabetic retinopathy double blind, randomized, sham-controlled studypt_BR
dc.typeArtigopt_BR
dc.publisher.countryOutrospt_BR
dc.identifier.doi10.4172/2155-9570.1000364-
dc.publisher.departmentFaculdade de Medicina - FM (RG)pt_BR
Aparece nas coleções:FM - Artigos publicados em periódicos

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
Artigo - Luiz Guilherme Azevedo de Freitas - 2014.pdf471,78 kBAdobe PDFThumbnail
Baixar/Abrir


Este item está licenciada sob uma Licença Creative Commons Creative Commons